Short answer
PHIBRO ANIMAL HEALTH CORP (PAHC) filed its Q4 2025 10-Q quarterly report on Feb 4, 2026 for the quarter ended Dec 31, 2025. Quarterly revenue was $374M (up 20.9% year over year) with net income of $27M.
Q4 2025 key financials · XBRL
- Revenue
- $374M
- +20.9% YoY · +2.8% QoQ
- Net income
- $27M
- +762.1% YoY · +3.5% QoQ
- Operating margin
- 13.5%
- Gross margin
- 35.5%
- EPS (diluted)
- $0.67
- +737.5% YoY · +3.1% QoQ
Source: XBRL data from the PHIBRO ANIMAL HEALTH CORP (PAHC) Q4 2025 10-Q on SEC EDGAR. USD.
PHIBRO ANIMAL HEALTH CORP Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No new or materially changed risk factors reported since most recent 10-K filing
- Regulatory compliance risk from evolving animal health product standards remains material, potentially impacting product approvals
- Operational risk tied to supply chain disruptions noted, with possible near-term delays affecting production timelines
- Market risk from increased competition in animal health sector, pressure on pricing and market share persistence
- Financial risk related to working capital management and ensuring liquidity for ongoing operations amid uncertain market conditions
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PHIBRO ANIMAL HEALTH CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.